A new method of modeling the multi-stage decision-making process of CRT using machine learning with uncertainty quantification

Read original: arXiv:2309.08415 - Published 4/30/2024 by Kristoffer Larsen, Chen Zhao, Joyce Keyak, Qiuying Sha, Diana Paez, Xinwei Zhang, Guang-Uei Hung, Jiangang Zou, Amalia Peix, Weihua Zhou
Total Score

0

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • This study aimed to develop a multi-stage machine learning model to predict the response of heart failure patients to cardiac resynchronization therapy (CRT).
  • The model uses uncertainty quantification to determine if additional data from single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) is needed to make accurate predictions, beyond the baseline clinical variables and electrocardiogram (ECG) features.
  • The performance of the multi-stage model was compared to ensemble models that used either clinical/ECG data or clinical/ECG plus SPECT MPI data.

Plain English Explanation

The researchers wanted to create a machine learning model that could predict how well heart failure patients would respond to a treatment called cardiac resynchronization therapy (CRT). CRT is a type of pacemaker that helps the two lower chambers of the heart (ventricles) beat in a more coordinated way, which can improve the heart's ability to pump blood.

To build their model, the researchers used data from 218 heart failure patients who had undergone CRT. They looked at the patients' clinical information, ECG results (which measure the electrical activity of the heart), and SPECT MPI scans (which show blood flow in the heart muscle).

The researchers' multi-stage model first used the clinical and ECG data to make a prediction. If the model was unsure about the prediction, it would then also use the SPECT MPI data to make a more informed decision. This approach allowed the model to avoid collecting the SPECT MPI data for every patient, which can be time-consuming and expensive.

The performance of the multi-stage model was similar to a model that used both the clinical/ECG data and the SPECT MPI data. However, the multi-stage model only needed the SPECT MPI data for about half of the patients, which could save time and resources in a clinical setting.

Technical Explanation

The researchers developed a multi-stage machine learning model to predict cardiac resynchronization therapy (CRT) response in heart failure (HF) patients. The model used a combination of clinical variables and electrocardiogram (ECG) features in the first stage, and then incorporated single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) features in the second stage if the uncertainty quantification from the first stage indicated that the additional data was necessary.

The researchers enrolled 218 HF patients who had undergone rest-gated SPECT MPI. CRT response was defined as an increase in left ventricular ejection fraction (LVEF) of more than 5% at a 6-month follow-up. They created two ensemble models: Ensemble 1 used only the clinical variables and ECG features, while Ensemble 2 used the clinical/ECG features plus the SPECT MPI data.

The multi-stage model performed similarly to Ensemble 2 in terms of area under the curve (AUC), accuracy, sensitivity, and specificity. However, the multi-stage model only required the SPECT MPI data for 52.7% of the patients, demonstrating that it was able to use uncertainty quantification to determine when additional data was needed.

Critical Analysis

The study's findings suggest that the multi-stage model's use of uncertainty quantification can help optimize data collection for CRT response prediction, potentially saving time and resources without sacrificing performance. However, the researchers note that the model was tested on a relatively small sample size, and further validation on larger, more diverse patient populations would be necessary to assess its generalizability.

Additionally, the study did not explore the potential for multi-task learning approaches that could leverage additional clinical data or other modalities to further improve the model's predictive capabilities. Investigating the integration of other relevant data sources, such as genetic or imaging biomarkers, could potentially enhance the model's ability to identify patients most likely to benefit from CRT.

Conclusion

This study demonstrates the potential of a multi-stage machine learning approach that leverages uncertainty quantification to streamline data collection and improve the prediction of CRT response in heart failure patients. By selectively incorporating additional SPECT MPI data only when necessary, the model was able to maintain similar performance to a more data-intensive approach, highlighting the value of tailoring data requirements to individual patient needs. Further research is needed to validate the model's effectiveness in larger and more diverse patient populations, as well as explore opportunities for incorporating additional data sources to enhance its predictive capabilities.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Total Score

0

A new method of modeling the multi-stage decision-making process of CRT using machine learning with uncertainty quantification

Kristoffer Larsen, Chen Zhao, Joyce Keyak, Qiuying Sha, Diana Paez, Xinwei Zhang, Guang-Uei Hung, Jiangang Zou, Amalia Peix, Weihua Zhou

Aims. The purpose of this study is to create a multi-stage machine learning model to predict cardiac resynchronization therapy (CRT) response for heart failure (HF) patients. This model exploits uncertainty quantification to recommend additional collection of single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) variables if baseline clinical variables and features from electrocardiogram (ECG) are not sufficient. Methods. 218 patients who underwent rest-gated SPECT MPI were enrolled in this study. CRT response was defined as an increase in left ventricular ejection fraction (LVEF) > 5% at a 6+-1 month follow-up. A multi-stage ML model was created by combining two ensemble models: Ensemble 1 was trained with clinical variables and ECG; Ensemble 2 included Ensemble 1 plus SPECT MPI features. Uncertainty quantification from Ensemble 1 allowed for multi-stage decision-making to determine if the acquisition of SPECT data for a patient is necessary. The performance of the multi-stage model was compared with that of Ensemble models 1 and 2. Results. The response rate for CRT was 55.5% (n = 121) with overall male gender 61.0% (n = 133), an average age of 62.0+-11.8, and LVEF of 27.7+-11.0. The multi-stage model performed similarly to Ensemble 2 (which utilized the additional SPECT data) with AUC of 0.75 vs. 0.77, accuracy of 0.71 vs. 0.69, sensitivity of 0.70 vs. 0.72, and specificity 0.72 vs. 0.65, respectively. However, the multi-stage model only required SPECT MPI data for 52.7% of the patients across all folds. Conclusions. By using rule-based logic stemming from uncertainty quantification, the multi-stage model was able to reduce the need for additional SPECT MPI data acquisition without sacrificing performance.

Read more

4/30/2024

🤔

Total Score

0

Continuous max-flow augmentation of self-supervised few-shot learning on SPECT left ventricles

'Ad'am Istv'an SzH{u}cs, B'ela K'ari, Oszk'ar P'artos

Single-Photon Emission Computed Tomography (SPECT) left ventricular assessment protocols are important for detecting ischemia in high-risk patients. To quantitatively measure myocardial function, clinicians depend on commercially available solutions to segment and reorient the left ventricle (LV) for evaluation. Based on large normal datasets, the segmentation performance and the high price of these solutions can hinder the availability of reliable and precise localization of the LV delineation. To overcome the aforementioned shortcomings this paper aims to give a recipe for diagnostic centers as well as for clinics to automatically segment the myocardium based on small and low-quality labels on reconstructed SPECT, complete field-of-view (FOV) volumes. A combination of Continuous Max-Flow (CMF) with prior shape information is developed to augment the 3D U-Net self-supervised learning (SSL) approach on various geometries of SPECT apparatus. Experimental results on the acquired dataset have shown a 5-10% increase in quantitative metrics based on the previous State-of-the-Art (SOTA) solutions, suggesting a good plausible way to tackle the few-shot SSL problem on high-noise SPECT cardiac datasets.

Read more

5/10/2024

Total Score

0

A Staged Approach using Machine Learning and Uncertainty Quantification to Predict the Risk of Hip Fracture

Anjum Shaik, Kristoffer Larsen, Nancy E. Lane, Chen Zhao, Kuan-Jui Su, Joyce H. Keyak, Qing Tian, Qiuying Sha, Hui Shen, Hong-Wen Deng, Weihua Zhou

Despite advancements in medical care, hip fractures impose a significant burden on individuals and healthcare systems. This paper focuses on the prediction of hip fracture risk in older and middle-aged adults, where falls and compromised bone quality are predominant factors. We propose a novel staged model that combines advanced imaging and clinical data to improve predictive performance. By using CNNs to extract features from hip DXA images, along with clinical variables, shape measurements, and texture features, our method provides a comprehensive framework for assessing fracture risk. A staged machine learning-based model was developed using two ensemble models: Ensemble 1 (clinical variables only) and Ensemble 2 (clinical variables and DXA imaging features). This staged approach used uncertainty quantification from Ensemble 1 to decide if DXA features are necessary for further prediction. Ensemble 2 exhibited the highest performance, achieving an AUC of 0.9541, an accuracy of 0.9195, a sensitivity of 0.8078, and a specificity of 0.9427. The staged model also performed well, with an AUC of 0.8486, an accuracy of 0.8611, a sensitivity of 0.5578, and a specificity of 0.9249, outperforming Ensemble 1, which had an AUC of 0.5549, an accuracy of 0.7239, a sensitivity of 0.1956, and a specificity of 0.8343. Furthermore, the staged model suggested that 54.49% of patients did not require DXA scanning. It effectively balanced accuracy and specificity, offering a robust solution when DXA data acquisition is not always feasible. Statistical tests confirmed significant differences between the models, highlighting the advantages of the advanced modeling strategies. Our staged approach could identify individuals at risk with a high accuracy but reduce the unnecessary DXA scanning. It has great promise to guide interventions to prevent hip fractures with reduced cost and radiation.

Read more

5/31/2024

Uncertainty Quantification on Clinical Trial Outcome Prediction
Total Score

0

Uncertainty Quantification on Clinical Trial Outcome Prediction

Tianyi Chen, Yingzhou Lu, Nan Hao, Capucine Van Rechem, Jintai Chen, Tianfan Fu

The importance of uncertainty quantification is increasingly recognized in the diverse field of machine learning. Accurately assessing model prediction uncertainty can help provide deeper understanding and confidence for researchers and practitioners. This is especially critical in medical diagnosis and drug discovery areas, where reliable predictions directly impact research quality and patient health. In this paper, we proposed incorporating uncertainty quantification into clinical trial outcome predictions. Our main goal is to enhance the model's ability to discern nuanced differences, thereby significantly improving its overall performance. We have adopted a selective classification approach to fulfill our objective, integrating it seamlessly with the Hierarchical Interaction Network (HINT), which is at the forefront of clinical trial prediction modeling. Selective classification, encompassing a spectrum of methods for uncertainty quantification, empowers the model to withhold decision-making in the face of samples marked by ambiguity or low confidence, thereby amplifying the accuracy of predictions for the instances it chooses to classify. A series of comprehensive experiments demonstrate that incorporating selective classification into clinical trial predictions markedly enhances the model's performance, as evidenced by significant upticks in pivotal metrics such as PR-AUC, F1, ROC-AUC, and overall accuracy. Specifically, the proposed method achieved 32.37%, 21.43%, and 13.27% relative improvement on PR-AUC over the base model (HINT) in phase I, II, and III trial outcome prediction, respectively. When predicting phase III, our method reaches 0.9022 PR-AUC scores. These findings illustrate the robustness and prospective utility of this strategy within the area of clinical trial predictions, potentially setting a new benchmark in the field.

Read more

6/19/2024